73 related articles for article (PubMed ID: 2353038)
21. [Results of intra-arterial administration of PGE1 prostaglandin].
Ciostek P; Kostewicz W; Górski G
Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
[TBL] [Abstract][Full Text] [Related]
22. [Complex intra-arterial, detoxicating, and dietetic treatment of intermittent claudication].
van der Molen HR; Lukkes J; Ritter K
Zentralbl Phlebol; 1968 Aug; 7(3):230-47. PubMed ID: 4879629
[No Abstract] [Full Text] [Related]
23. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
24. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
[No Abstract] [Full Text] [Related]
25. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
[TBL] [Abstract][Full Text] [Related]
26. [On conserative treatment of arterial circulation disorders].
Hänel W
Ther Ggw; 1968 Apr; 107(4):546-8. PubMed ID: 5672326
[No Abstract] [Full Text] [Related]
27. Peripheral thrombolysis for acute-onset claudication. Thrombolysis Study Group.
Braithwaite BD; Tomlinson MA; Walker SR; Davies B; Buckenham TM; Earnshaw JJ
Br J Surg; 1999 Jun; 86(6):800-4. PubMed ID: 10383582
[TBL] [Abstract][Full Text] [Related]
28. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
Schafé MK
Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
[No Abstract] [Full Text] [Related]
29. [Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities].
Pokrovskiĭ AV; Chupin AV; Kalinin AA; Markosian AA; Zamskiĭ KS; Kolosov RV
Angiol Sosud Khir; 2003; 9(2):19-24. PubMed ID: 12811370
[TBL] [Abstract][Full Text] [Related]
30. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
Rudofsky G
Wien Klin Wochenschr; 1988 Jul; 100(14):484-8. PubMed ID: 3062906
[TBL] [Abstract][Full Text] [Related]
31. [Intra-arterial lidocaine in arteriography of lower extremities. Analgesic action and side-effects].
Bjerkvik PS
Tidsskr Nor Laegeforen; 1982 May; 102(13):750-2. PubMed ID: 7157257
[No Abstract] [Full Text] [Related]
32. [Femoral arteriography. A simple method not requiring sterilized equipment].
Vassal J
Tidsskr Nor Laegeforen; 1972 Jan; 92(3):172-4. PubMed ID: 5016094
[No Abstract] [Full Text] [Related]
33. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
34. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
[TBL] [Abstract][Full Text] [Related]
35. [Intramuscular injections of PGE1 in patients with severe claudication].
Corsi M; Laurora G; Cesarone MR
Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):59-63. PubMed ID: 10658447
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial lidocaine: an effective analgesic for peripheral angiography.
Gordon IJ; Westcott JL
Radiology; 1977 Jul; 124(1):43-5. PubMed ID: 866655
[TBL] [Abstract][Full Text] [Related]
37. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
[TBL] [Abstract][Full Text] [Related]
38. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
[TBL] [Abstract][Full Text] [Related]
39. [Internal medical angiological treatment].
Thiele P; Heidelmann G
Z Gesamte Inn Med; 1969 Feb; 24(4):116-9. PubMed ID: 5796654
[No Abstract] [Full Text] [Related]
40. [On the treatment of intermittent claudication. Clinical studies of pharmacological effects].
Koppelmann J; Friedebold G
Med Klin; 1969 Jan; 64(5):199-202. PubMed ID: 5772759
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
